Skip to main content

Table 2 Univariate analysis of predictors for all-cause mortality

From: Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure

 

HR (95% CI)

P value

Age (per year increase)

1.00 (1.00, 1.01)

0.016

Male

0.55 (0.41, 0.73)

 < 0.001

Diabetes

1.01 (0.74, 1.39)

0.936

Hypertension

0.87 (0.66, 1.15)

0.327

Ischemic heart failure

1.12 (0.82, 1.54)

0.483

NYHA

  

II

1.00

 

III

1.63 (1.05, 2.54)

0.031

IV

2.01 (1.25, 3.21)

0.004

Heart rate (per beats/min increase)

1.00 (0.99, 1.00)

0.521

Systolic blood pressure (per mmHg increase)

0.99 (0.99, 1.00)

0.023

Diastolic blood pressure (per mmHg increase)

0.98 (0.97, 0.99)

0.001

Potassium (per mmol/L increase)

1.08 (0.81, 1.42)

0.612

Uric acid (per mg/dL increase)

1.05 (0.99, 1.10)

0.057

ALT (per U/L increase)

1.00 (1.00, 1.00)

0.598

AST (per U/L increase)

1.00 (1.00, 1.00)

0.659

proBNP (per ng/L increase)

1.00 (1.00, 1.00)

 < 0.001

CRP (per mg/L increase)

1.01 (0.99, 1.03)

0.082

Anemia

1.22 (0.82, 1.80)

0.325

LVEF (per 1 unit increase)

0.98 (0.97, 0.99)

0.001

Pulmonary hypertension

1.69 (1.26, 2.28)

0.001

Tricuspid regurgitation

  

No

1.00

 

Mild

0.96 (0.54, 1.71)

0.890

Moderate

1.16 (0.65, 2.09)

0.619

Severe

1.74 (0.96, 3.14)

0.068

RVDd (per mm increase)

1.02 (1.00, 1.04)

0.056

Body mass index (per kg/M2 increase)

0.98 (0.95, 1.00)

0.082

Antisterone

1.13 (0.70, 1.81)

0.622

ACEI/ARB

0.94 (0.67, 1.31)

0.699

Beta-blocker

0.79 (0.57, 1.10)

0.163

Aspirin

1.08 (0.82, 1.44)

0.583

  1. NYHA New York Heart Association functional class, ALT alanine aminotransferase, AST aspartate aminotransaminase, LVEF left ventricular ejection fraction, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blocker